期刊文献+

替罗非班对急性心肌梗死急诊冠状动脉介入治疗冠状动脉微循环的影响 被引量:10

Effect of tirofiban hydrochloride on coronary microcirculation of acute myocardial infarction in emergency percutaneous coronary interventional therapy
下载PDF
导出
摘要 目的探讨并评价采用替罗非班对心肌梗死患者急诊实施冠状动脉介入治疗微循环产生的影响。方法将我院收治的ST段抬高性急性心肌梗死患者62例随机分成观察组32例与对照组30例,对比分析两组患者的临床状况、心电图ST段回落幅度、主要心脏不良事件及住院期间出血事件发生率等。结果观察组1.5 h心电图ST段回落幅度大于对照组,治疗前后比较差异具有统计学意义(P<0.05);观察组发生牙龈出血4例,对照组3例,两组均未见颅内出血与血小板减少症。术后观察组凝血因子TF与vWF均低于对照组,两组比较差异具有统计学意义(P<0.05),两组患者的PT与AFTT之间差异无统计学意义。结论采用替罗非班对心肌梗死患者急诊实施冠状动脉介入手术能够争取更多时间,以防止大量心肌细胞发生永久性坏死,有效解除心肌微循环障碍,明显降低无复流现象。 Objective To evaluate the effect of tirofiban hydrochloride on coronary microcirculation of acute myocardial infarction(AMI)in emergency percutaneous coronary interventional therapy.Methods 62 AMI patients with ST segment elevation were divided into observation group(32 cases) and control group(30 cases),the clinical status,the drop rate of electrocardiogram ST segment,major adverse cardiac events and bleeding events were compared between the two groups.Results After treatment,1.5 h ST segment of electrocardiogram of the observation group fell,more than those of control group(P0.05);There were 4 cases of gingival hemorrhage in observation group while 3 cases in the control group.There was no intracranial hemorrhage and thrombocytopenia in the two groups.TF and vWF of observation group were lower than those of the control group(P0.05),PT and AFTT of the two groups had no obvious difference(P0.05).Conclusion Tirofiban hydrochloride has better effects on coronary microcirculation of acute myocardial infarction in emergency percutaneous coronary interventional therapy.
作者 张若兰
出处 《实用药物与临床》 CAS 2012年第8期477-478,共2页 Practical Pharmacy and Clinical Remedies
关键词 替罗非班 急性心肌梗死 冠状动脉介入治疗 冠状动脉微循环 Tirofiban hydrochloride Acute myocardial infarction Coronary intervention Coronary microcirculation
  • 相关文献

参考文献4

二级参考文献55

共引文献30

同被引文献107

  • 1杨新春,徐立,王乐丰,葛永贵,王红石,丁枭伟,王文君,邹阳春,李惟铭,刘宇.国产替罗非班对急性心肌梗死患者急诊介入治疗术后冠状动脉血流和心肌灌注影响的研究[J].中国循环杂志,2006,21(1):4-7. 被引量:91
  • 2唐强,郭来敬,张树和,王智,曲华清,颜东,唐群中,史震涛.盐酸替罗非班在ST段抬高急性心肌梗死急诊PCI中的安全性分析[J].心肺血管病杂志,2007,26(1):21-23. 被引量:27
  • 3李冰,王建.辛伐他汀对不稳定性心绞痛患者脂联素和超敏C反应蛋白水平的影响[J].医学临床研究,2007,24(3):441-442. 被引量:7
  • 4黄浙勇,葛均波,张少衡,黄榕翀,沈雳,崔洁,钱菊英,孙爱军,邹云增.猪急性心肌梗死模型发生心室颤动的相关因素分析[J].中国实验动物学报,2007,15(5):351-354. 被引量:16
  • 5Dimopoulos K, Dudek D, Piscione F, et al. Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: Implications on opfimisation of timing of treatment from the CARESS-in-AMI trial. Int J Cardiol,2012,154(3) :275-281.
  • 6Chen Q, Yang Y, Liu Y, et al. Safety and effectiveness of percu- taneous coronary intervention (PCI) in elderly patients, a 5-year consecutive study of 201 cases with PCI. Arch Gerontol Geriatr, 2010, 51(3) :312-316.
  • 7Heestermans AA, Hermanides RS, Gosselink AT, et al. A com- parison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing prima- ry PCI : Insights from the Zwolle acute myocardial infarction regis- try. Neth Heart J, 2010, 18(12) :592-597.
  • 8Pedersen TR, Cater NB, Faergeman O, et al. Comparison of ator- vastatin 80 rag/day versus simvastatin 20 to 40 mg/day on frequen- cy of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering I IDEAL] trial). Am J Cardiol, 2010, 106(3) :354-359.
  • 9Erglis A, Narbute I, Jegere S. Left main coronary artery disease in 2011 : CABG or PCI? Minerva Med, 2011, 102(5) :381-390.
  • 10Mckellar GE, Mccarey DW, Sattar N, et al. Role for TNF in ath- erosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol, 2009, 6(6) :410-417.

引证文献10

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部